Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pan... Autonomix, we're developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. This opens us up to a world of possibilities in the field of electrophysiology. Clinical trials start this year for the treatment of pancreatic cancer pain and pancreatitis pain. Mehr anzeigen
THE WOODLANDS, TX, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies...
Growing global patent portfolio to over 120 patents with 80 issued patents and over 40 pending patent applications Previously completed preclinical study evaluating targeted nerve ablation...
THE WOODLANDS, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies...
Continued efforts to build team and infrastructure required to support clinical and regulatory initiatives in anticipation of the FDA approval process for first-in-class catheter-based sensing...
First-in-class catheter-based sensing technology designed to sense neuronal signals that indicate pain or disease and destroy those nerves at the source Company expects to submit an...
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.82 | -23.3618233618 | 3.51 | 3.51 | 2.65 | 116903 | 2.92896522 | CS |
| 4 | -0.485 | -15.2755905512 | 3.175 | 4.58 | 2.65 | 827517 | 3.88193953 | CS |
| 12 | -7.91 | -74.6226415094 | 10.6 | 19.3 | 2.65 | 879377 | 9.61934807 | CS |
| 26 | -16.71 | -86.1340206186 | 19.4 | 42.4 | 2.65 | 2607057 | 23.70286074 | CS |
| 52 | -149.31 | -98.2302631579 | 152 | 152 | 2.65 | 1493185 | 23.77949724 | CS |
| 156 | -149.31 | -98.2302631579 | 152 | 152 | 2.65 | 1493185 | 23.77949724 | CS |
| 260 | -149.31 | -98.2302631579 | 152 | 152 | 2.65 | 1493185 | 23.77949724 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
